A novel prognostic model for Japanese patients with newly diagnosed bone-metastatic hormone-naïve prostate cancer.

Yasuhide Miyoshi Masato YasuiShuko YoneyamaTakashi KawaharaYoshihiro NakagamiYoshimasa OhnoJunpei IizukaKazunari TanabeYasunobu HashimotoHideyasu TsumuraKen-Ichi TabataMasatsugu IwamuraAkihiro YanoSatoru KawakamiHiroji Uemura

Published in: BJUI compass (2020)

We developed a prognostic model for mHNPC patients that consisted of CHAARTED risk classifications, GS, and Hb. Our prognostic model could significantly stratify the prognosis of patients with LVD and HVD into two groups each. This model might be a good reference for shared decision making between patients and physicians on the initial treatment for mHNPC.

Keyphrases

newly diagnosed
prostate cancer
end stage renal disease
ejection fraction
chronic kidney disease
squamous cell carcinoma
small cell lung cancer
primary care
peritoneal dialysis
prognostic factors
radical prostatectomy
body composition
bone mineral density
replacement therapy